Revista espanola de medicina nuclear · 2011
[18F-FDG PET/CT with retrograde filling of the urinary bladder in the assessment of malignant pelvic disease].
Оценочное исследованиеСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
García Vicente A M, Núñez García A, Palomar Muñoz A, Pilkington Woll J P, Bellón Guardia M E, González García B, Soriano Castrejón A
Аннотация
AIM: To assess the role of PET/CT with retrograde filling of urinary bladder (RFUB) in the assessment of pelvic malignancy in patients with urothelial or gynecological tumors.
MATERIAL AND METHODS: A retrospective longitudinal analysis based on 62 studies belonging to 52 patients was performed. All of them had a history of pelvic malignancy (29 urothelial and 23 gynecological) and 42 had undergone previous treatments. All patients underwent a standard PET/CT protocol. Inclusion criteria were radiological alterations in pelvic organs or increased urinary activity of (18)F-FDG that hindered evaluation of the pelvic structures. Pathological pelvic locations were assessed as the additional value of PET/CT with RFUB. The pathologic lesions were histologically or clinically evaluated with a minimum follow-up of 12 months.
RESULTS: Pelvic malignancy was confirmed in 33 cases, 16 of which were of urothelial origin. A total of 35/62 studies showed a pathologic PET/CT in pelvis, 4 of them were false positive and 2 false negative. In 19 cases, malignancy was detected in the bladder wall, 16 of which were true positive. No false negative was detected. Regarding standard imaging acquisition, RFUB helped to confirm or rule out bladder and/or gynecological disease in 54 cases.
CONCLUSION: Retrograde bladder filling is a highly recommended technique in the assessment of malignant pelvic disease, especially of bladder origin.
MATERIAL AND METHODS: A retrospective longitudinal analysis based on 62 studies belonging to 52 patients was performed. All of them had a history of pelvic malignancy (29 urothelial and 23 gynecological) and 42 had undergone previous treatments. All patients underwent a standard PET/CT protocol. Inclusion criteria were radiological alterations in pelvic organs or increased urinary activity of (18)F-FDG that hindered evaluation of the pelvic structures. Pathological pelvic locations were assessed as the additional value of PET/CT with RFUB. The pathologic lesions were histologically or clinically evaluated with a minimum follow-up of 12 months.
RESULTS: Pelvic malignancy was confirmed in 33 cases, 16 of which were of urothelial origin. A total of 35/62 studies showed a pathologic PET/CT in pelvis, 4 of them were false positive and 2 false negative. In 19 cases, malignancy was detected in the bladder wall, 16 of which were true positive. No false negative was detected. Regarding standard imaging acquisition, RFUB helped to confirm or rule out bladder and/or gynecological disease in 54 cases.
CONCLUSION: Retrograde bladder filling is a highly recommended technique in the assessment of malignant pelvic disease, especially of bladder origin.
Предметные рубрики MeSH
Administration, IntravesicalAdultAgedAged, 80 and overArtifactsFalse Negative ReactionsFalse Positive ReactionsFemaleFluorine RadioisotopesFluorodeoxyglucose F18HumansMaleMiddle AgedNeoplasm InvasivenessOsmolar ConcentrationPelvic NeoplasmsPositron-Emission TomographyRadiopharmaceuticalsRetrospective StudiesSodium ChlorideTherapeutic IrrigationTomography, X-Ray ComputedUrinary Bladder